The Europe Hypodermic Needles Market would witness market growth of 2.9% CAGR during the forecast period (2022-2028).
Disposable needles are significantly more frequent in medicine than reusable needles, although are nonetheless essential in some scientific applications. Disposable needles are inserted in a plastic or aluminum hub that is press-fit or twist-on and attached to the syringe barrel. These are sometimes referred as Luer Lock connectors after the Luer-Lok trademark. Two of the most important pieces of disposable hypodermic needles are the male and female luer lock and hub, which are manufactured by pharmaceutical equipment manufacturers.
Medical professionals, including dentists, phlebotomists, pharmacists, physicians, nurses, and paramedics, are the most common users of hypodermic needles, but patients may also use them. This is especially common among type 1 diabetics, who may need many insulin injections throughout the day. Patients with asthma as well as other severe allergies are also affected. Desensitization injections or injectable drugs to use as first assistance in the event of a severe allergic reaction may be required for such patients. Such patients frequently carry a syringe containing epinephrine, diphenhydramine, or dexamethasone in the latter situation. A quick injection of one of these medications may be able to stop a life-threatening allergic reaction.
Germany's medical equipment sector is strong and well-established. Brands like Siemens, Carl Zeiss, and Drägerwerk, which date back to the late 1800s, can attest to a long history of creating high-quality medical equipment, with a focus on precision medical and dental tools, diagnostic imaging, and optical technology. According to the International Trade Administration, after the United States and Japan, Germany has the world's third-biggest medical technology market, and it is also the largest European market, twice the size of France and three times the size of Italy, the United Kingdom, and Spain. In addition, the German medical device market was placed first, and it remains one of the most valuable healthcare industries in the region.
In addition, the prevalence of diabetes is significantly high in this region. A considerable number of people are being diagnosed with diabetes or obesity, which can lead to diabetes later. According to the European Unit of the World Health Organization, in the European Region, around 60 million individuals have diabetes, accounting for 10.3% of men and 9.6% of women aged 25 and over.
The Germany market dominated the Europe Hypodermic Needles Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $259.7 million by 2028. The UK market is poised to grow at a CAGR of 2% during (2022 - 2028). Additionally, The France market would display a CAGR of 3.6% during (2022 - 2028).
Based on Product, the market is segmented into Safety and Non-safety. Based on Application, the market is segmented into Drug Delivery, Vaccination and Blood Specimen Collection. Based on End Users, the market is segmented into Hospital, Diabetic Patients, Family Practitioners, Psychiatry and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Hypodermic Needles Market Size will Hit $4.2 Billion by 2028, at a CAGR of 3.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, Cardinal Health, Inc., B. Braun Melsungen AG, McKesson Corporation, Retractable Technologies, Inc., Connecticut Hypodermics, Inc., Exelint International, Co., and i-Tech Medics Private Limited.
By Product
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
